Two-Year Therapeutic Efficacy and Safety of Initial Triple Combination of Metformin, Sitagliptin, and Empagliflozin in Drug-Naïve Type 2 Diabetes Mellitus Patients (Diabetes Metab J 2024;48:253-64)

Author: Young-Hwan PARK ¹ ; Minji SOHN ; Soo LIM
Author Information

1. Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea
Publication Type:Response
From:Diabetes & Metabolism Journal 2024;48(5):1012-1013
CountryRepublic of Korea
Language:English